The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
 
Kevin R Reyes
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - Raydiant Oximetry
Travel, Accommodations, Expenses - Dendreon
 
Xiaolin Zhu
Employment - Exelixis (I)
 
Tanya Jindal
No Relationships to Disclose
 
Prianka Deshmukh
No Relationships to Disclose
 
Ivan de Kouchkovsky
No Relationships to Disclose
 
Vipul Kumar
No Relationships to Disclose
 
Edward Maldonado
No Relationships to Disclose
 
Daniel H Kwon
Stock and Other Ownership Interests - Invitae
 
Emily Chan
Research Funding - Ibex (Inst)
 
Sima P. Porten
Honoraria - photocure
Consulting or Advisory Role - Bristol-Myers Squibb; KDx Diagnostics; Photocure; Protara Therapeutics
Research Funding - Photocure (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Hala Borno
Employment - Collective Health (I); Trial Library; Waymark (I)
Leadership - Collective Health (I); Trial Library; Trial Library; Waymark (I)
Stock and Other Ownership Interests - Collective Health (I); Trial Library; Waymark (I)
Honoraria - AstraZeneca; BMS; ConcertAI; Dendreon
Consulting or Advisory Role - AstraZeneca; BMS; Dendreon
 
Rohit Bose
No Relationships to Disclose
 
Arpita Desai
Consulting or Advisory Role - Dendreon; Janssen Oncology
 
Rahul Raj Aggarwal
Honoraria - Clovis Oncology
Consulting or Advisory Role - Advanced Accelerator Applications; Alessa Therapeutics; Alessa Therapeutics; Amgen; AstraZeneca; Axiom Biotechnologies; Clovis Oncology; Dendreon; Jubilant Pharmaceuticals; Merck; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BioXCel therapeutics (Inst); Cancer Targeted Technology (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen; Johnson and Johnson
Consulting or Advisory Role - Fortis; Janssen Oncology; Teon Therapeutics
 
Lawrence Fong
Stock and Other Ownership Interests - Actym Therapeutics; Alector; Atreca; BioAtla; Bolt Biotherapeutics; ImmunoGenesis; Nutcracker Therapeutics, Inc.; RAPT Therapeutics; Senti Biosciences; SOTERIA Precision Medicine; Sutro Biopharma
Consulting or Advisory Role - Alector; AstraZeneca; Atreca; BioAtla; Bolt Biotherapeutics; Bristol-Myers Squibb; Dendreon; EMD Serono; Innovent Biologics; Janssen Oncology; Merck; Nutcracker Therapeutics, Inc.; RAPT Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Jonathan Chou
Stock and Other Ownership Interests - Array BioPharma (I); Atara Biotherapeutics (I); Bluebird Bio (I); Celgene (I); Exelixis (I)
Consulting or Advisory Role - Exai Bio
Research Funding - Amgen (Inst)
 
Terence W. Friedlander
Leadership - Med BioGene
Honoraria - Astellas Scientific and Medical Affairs Inc; AstraZeneca/MedImmune; EMD Serono
Consulting or Advisory Role - Abbvie; Astellas Pharma; Basilea; Dava Oncology; Dendreon; EMD Serono; Foundation Medicine; Merck
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen; Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche; Jounce Therapeutics
 
Vadim S Koshkin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - Clovis Oncology; Endocyte; Janssen Oncology; Nektar; Taiho Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen